• Delorean's SA1 bioenergy facility to produce biogenic food-grade liquid carbon dioxide
• 10-year offtake agreement with Supagas, with 5-year extension option
• Supagas to take all liquid CO2 produced on a 'take or pay' basis
• Delorean and Supagas to share carbon credits generated from biogenic LCO2 production

Delorean Corporation Ltd (ASX: DEL) has provided a further update on its binding long-term agreement with Supagas Pty Ltd for the supply of biogenic food-grade liquid carbon dioxide (LCO2) to be produced from Delorean's SA1 bioenergy facility currently under construction in Edinburgh Parks, near Adelaide in South Australia. The SA1 project will process 70,000 tonnes per annum of commercial and municipal organic waste diverted from landfill using anaerobic digestion to produce biogas for renewable electricity and gas. Biogenic LCO2 will be manufactured as a by-product from the further upgrade of biogas to mains-grade biomethane for injection into the gas network. Under the 10-year offtake agreement, with a further 5-year extension option subject to both parties being mutually satisfied with commercial terms, Supagas will take all the liquid CO2 produced by Delorean on a 'take or pay' basis, delivered to Supagas' LCO2 storage tanks to be built onsite at the SA1 facility. The agreement is subject to Delorean's final investment decision on the installation of biomethane upgrade and LCO2 processing equipment at the SA1 facility, as well as final permitting and compliance, with first LCO2 production expected in Q3 FY2026. Delorean and Supagas will share equally any carbon credits generated from the production of biogenic LCO2, enabling each party to realise the value of their share of carbon credits. Delorean estimates that the agreement will deliver an uplift in net profitability of the SA1 project of between $15-25m over the term of the agreement.

Delorean estimates that the Supagas offtake agreement will deliver an uplift in net profitability of the SA1 project of between $15-25m over the 10-year term of the agreement.

Delorean's SA1 bioenergy facility is expected to commence production of biogenic food-grade liquid carbon dioxide in Q3 FY2026, subject to final investment decision, permitting, and commissioning.